The Board of Directors of Fuji Pharma Co., Ltd. has authorized a buyback plan on February 9, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,457 JPY | -2.02% | -1.89% | -16.22% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.22% | 226M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- 4554 Stock
- News Fuji Pharma Co., Ltd.
- Fuji Pharma Co., Ltd. authorizes a Buyback Plan.